Depuy Synthes Products, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$618Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
1,135clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Attune $95M associated (2023-2025)
- Reclaim $17M associated (2023-2025)
- Actis $16M associated (2023-2025)
- Summit $14M associated (2023-2025)
- Pinnacle $13M associated (2023-2025)
- Na $11M associated (2023-2025)
- Sigma $7.8M associated (2023-2025)
- Omnispan Orthocord $7.1M associated (2023-2025)
- Rapidloc Pds Panacryl $6.4M associated (2023-2025)
- Rigidloop $6.3M associated (2023-2025)
- Healix Knotless Peek $6.2M associated (2023-2025)
- Pinnacle Gription Tf $5.7M associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Andrew Cooper | Clearwater, FL | Orthopaedic Surgery | $101,510,107.68 |
| Charles Decook | Cumming, GA | Orthopaedic Surgery | $45,557,608.41 |
| Hyun Bae | Santa Monica, CA | Orthopaedic Surgery of The Spine | $38,024,840.81 |
| John Callaghan | Iowa City, IA | Orthopaedic Surgery | $23,166,122.84 |
| Daniel Berry | Rochester, MN | Orthopaedic Surgery | $21,323,816.55 |
| Joel Matta | Vail, CO | Orthopaedic Surgery | $18,561,002.11 |
| Thomas Fehring | Charlotte, NC | Orthopaedic Surgery | $18,240,671.01 |
| Douglas Dennis | Denver, CO | Orthopaedic Surgery | $16,524,859.23 |
| Chitranjan Ranawat | New York, NY | $14,926,637.31 | |
| Hugh West | Murray, UT | Orthopaedic Surgery | $13,618,684.39 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.